Search
Search Results
##search.searchResults.foundPlural##
-
VON WILLEBRAND FACTOR, ANGIODYSPLASIA AND ANGIOGENESIS
3914PDF: 1663HTML: 8247Randi Fig: 223 -
VASCULAR ENDOTHELIAL GROWTH FACTOR IN CHILDREN WITH THALASSEMIA MAJOR PDF
1405PDF: 923HTML: 1138Figure 1 the correlation between frequency of blood transfusion and serum vascular endothelial growth factor (VEGF).: 223 -
ON THE VERSATILITY OF VON WILLEBRAND FACTOR
2956PDF: 1213HTML: 11427 -
SOLITARY PLASMACYTOMA
4232PDF: 2267HTML: 1412fIGURES 1,2: 272 -
Identification of Alpha Thalassemia, RNF 213 p.R4810K and PROC p.R189W among Children with Moyamoya Disease/Syndrome Alpha Thalassemia and RNF 213 Gene Mutation in Moyamoya
1084PDF: 796HTML: 264 -
PRACTICAL RECOMMENDATIONS FOR THE MANAGEMENT OF PATIENTS WITH ITP DURING THE COVID-19 PANDEMIC Recommendation for ITP management during COVID
2920PDF: 1014HTML: 645 -
NEW TREATMENTS FOR MYELODYSPLASTIC SYNDROMES
2104PDF: 1774HTML: 809 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
3034PDF: 1077HTML: 5655 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1549PDF: 1015HTML: 450 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
776PDF: 496HTML: 6287 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4421PDF: 1595HTML: 478 -
ENDOTHELIAL BIOMARKERS IN PATIENTS RECOVERED FROM COVID-19 ONE YEAR AFTER HOSPITAL DISCHARGE: A CROSS-SECTIONAL STUDY Endothelial biomarkers in COVID-19 recoverers one year after hospital discharge.
1417PDF: 798HTML: 417 -
POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
1432PDF: 497HTML: 18633Figure 1: 202Figure 2: 186Figure 3: 198Figure 4: 231Figure 5: 206 -
NOVEL DRUGS IN FOLLICULAR LYMPHOMA
5884PDF: 1596HTML: 1668Untitled: 276 -
PLASMACELL NEOPLASMS WITH SPREADING IN THE BLOOD AND TISSUES: EXTRAMEDULLARY MYELOMA DISEASE A RARE AGGRESSIVE FORM OF MULTIPLE MYELOMA (First of two parts) Extra Medullary Myeloma
2594HTML: 323PDF: 963 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4741PDF: 2025HTML: 18187 -
PATHOGENESIS AND TREATMENT OF THROMBOHEMORRHAGIC DIATHESIS IN ACUTE PROMYELOCYTIC LEUKEMIA
1966PDF: 878HTML: 10363Figures 1,2,3: 249 -
THE PROTHROMBOTIC STATE ASSOCIATED WITH SARS-COV-2 INFECTION: PATHOPHYSIOLOGICAL ASPECTS COVID and Thrombosis
2450PDF: 869HTML: 484 -
miR-155-5p PROMOTES CD34+ APOPTOSIS AND INHIBITS BONE MARROW HEMATOPOIESIS IN MYELODYSPLASTIC SYNDROMES BY RAC1/CREB/MIR-15B AXIS
834PDF: 940PDF Supp. Files: 105HTML: 259 -
HHVs AND LYMPHOPROLIFERATIVE DISORDERS
1519PDF: 878HTML: 3145
1 - 40 of 40 items







